SCHEMBL7196195

SCHEMBL7196195

O=C(O)C(O)(C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 5/20 0.50
▸ SRC P12931 1/20 0.46
▸ CYP1A2 P05177 2/20 0.45
▸ CES2 O00748 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ DAO P14920 1/20 0.42
▸ NAPRT Q6XQN6 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP2C9 P11712 1/20 0.41
▸ KEAP1 Q14145 1/20 0.40
▸ NFE2L2 Q16236 1/20 0.40
▸ MAPT P10636 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA4 P22748 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ PARP1 P09874 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL562162 0.91 CES1 (0.54) CES1SRCCYP1A2CES2TSHR
SCHEMBL7190673 0.84 CA12 (0.47) CES1SRCALDH1A1KEAP1NFE2L2
SCHEMBL2208136 0.84 CYP1A2 (0.54) CYP1A2TSHRDAONAPRTALDH1A1
SCHEMBL7782499 0.83 CES1 (0.52) CES1SRCCYP1A2CES2TSHR
SCHEMBL16516134 0.82 CES2 (0.55) CES1SRCCES2ALDH1A1MAPT
SCHEMBL7395954 0.80 CES1 (0.44) CES1SRCCYP1A2CES2TSHR
SCHEMBL10911193 0.80 CES1 (0.49) CES1SRCCES2TSHRDAO
SCHEMBL7542420 0.80 UNG (0.51) CES1SRCALDH1A1MAPTTDP1
SCHEMBL1646616 0.79 CES1 (0.56) CES1SRCCES2TSHRDAO
SCHEMBL15284434 0.79 CES1 (0.47) CES1SRCTSHRALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108659223-B Cyclodextrin derivative type photosensitive resin, preparation method thereof, resist composition based on cyclodextrin derivative type photosensitive resin and application of resist composition 中科院广州化学有限公司南雄材料生产基地 2020-12-04 — — CN disclosed
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 — — EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 — — US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 — — WO disclosed
US-4916161-A WET GRANULATION BRISTOL-MYERS SQUIBB (US) 1990-04-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 CES1 1995/4885SRC 2682/4885CYP1A2 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback